Related Experiment Video
Updated: Jan 11, 2026

Imaging and Analysis of Oil Red O-Stained Whole Aorta Lesions in an Aneurysm Hyperlipidemia Mouse Model
Published on: May 2, 2022
Diagnostic value of platelet to high-density lipoprotein cholesterol ratio in abdominal aortic aneurysms
Xiao Du1, Jin Xu2, Shilan Zhang3
1Department of Cardiology, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Insights
The platelet-to-HDL cholesterol ratio (PHR) is a novel biomarker for abdominal aortic aneurysm (AAA). Higher PHR levels indicate AAA presence and thrombosis, suggesting its utility as a rapid diagnostic indicator.
Area of Science:
- Cardiovascular Medicine
- Biomarker Discovery
- Medical Diagnostics
Background:
- Abdominal aortic aneurysm (AAA) presents a significant mortality risk.
- Current AAA diagnosis relies heavily on imaging, necessitating simpler screening biomarkers.
- The platelet-to-high-density lipoprotein cholesterol ratio (PHR) reflects systemic inflammation and hypercoagulable states.
Purpose of the Study:
- To investigate the clinical significance of the PHR as a biomarker for AAA.
- To evaluate PHR's diagnostic and predictive value in patients with AAA, including those with thrombosis.
Main Methods:
- A cohort study involving 156 AAA patients and 113 healthy controls.
- Serum PHR levels were calculated using [platelet count (1,000 cells/µl) / HDL-C (mmol/L)].
- Receiver operating characteristic (ROC) analysis and logistic regression were employed to assess predictive value and identify independent predictors.
Main Results:
- PHR levels were significantly elevated in AAA patients compared to controls (192.35 vs. 127.00, P < 0.001).
- PHR was even higher in AAA patients with thrombosis (220.61 vs. 161.80, P < 0.001).
- PHR demonstrated good predictive value for AAA diagnosis (AUC = 0.805) and for AAA with thrombosis (AUC = 0.814), and was an independent predictor for both conditions.
Conclusions:
- The PHR exhibits significant diagnostic value for abdominal aortic aneurysm.
- PHR can function as a rapid and effective screening indicator for clinical AAA diagnosis.
- Elevated PHR levels are associated with the presence of AAA and concomitant thrombosis.
Background:
Abdominal aortic aneurysm (AAA) is a disease with a relatively high mortality risk. Currently, diagnosis of AAA predominantly depends on imaging examinations, and there is an urgent need for simple and rapid screening biomarkers. The platelet to high-density lipoprotein cholesterol ratio (PHR) is an emerging biomarker reflects systemic inflammation and hypercoagulable states in cardiovascular diseases. The aim of this study is to elucidate the clinical significance of PHR in AAA.
Methods:
A total of 156 patients with AAA and 113 healthy controls were enrolled. Among them, 80 patients with AAA had concomitant thrombosis. Serum samples were collected upon admission to the hospital and before treatment. The equation for PHR calculation is: PHR = [platelet (1,000 cells/µl)/HDL-C (mmol/L)]. The optimal PHR cut-off was determined via ROC analysis, and logistic regression identified AAA predictors.
Results:
In this study, PHR level in patients with AAA was significantly higher than that of control group [127.00 (109.74, 163.42) vs. 192.35 (159.08, 231.66); <0.001]. Additionally, PHR value was even higher in AAA patients with thrombosis [161.80 (135.54, 193.41) vs. 220.61 (186.49, 262.27); <0.001]. ROC curve analysis revealed that PHR had a good predictive value for diagnosis of AAA, with an area under the curve (AUC) of 0.805. When it came to the diagnosis of AAA patients with thrombosis, the AUC of PHR was 0.814. Multivariate logistic regression analysis further demonstrated that PHR was an independent predictor in AAA (OR: 1.022, 95% CI: 1.012-1.031; P < 0.001) and AAA patients with thrombosis (OR: 1.016; 95% CI: 1.007-1.024; P < 0.001).
Conclusion:
PHR has good diagnostic value for AAA and can serve as a rapid screening indicator for its clinical diagnosis.
More Related Videos
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Peripheral Artery Disease I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

